APPLIED THERAPEUTICS INC's ticker is APLT and the CUSIP is 03828A101. A total of 66 filers reported holding APPLIED THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,066 | +94.5% | 1,633 | 0.0% | 0.00% | – |
Q2 2023 | $2,090 | +54.2% | 1,633 | -2.2% | 0.00% | – |
Q1 2023 | $1,355 | -42.9% | 1,670 | -46.5% | 0.00% | – |
Q4 2022 | $2,372 | -99.6% | 3,121 | +387.7% | 0.00% | – |
Q3 2022 | $595,000 | -97.3% | 640 | -97.2% | 0.00% | – |
Q2 2022 | $21,765,000 | +570.3% | 22,954 | +1391.5% | 0.00% | – |
Q1 2022 | $3,247,000 | -92.5% | 1,539 | -68.3% | 0.00% | – |
Q4 2021 | $43,408,000 | -16.6% | 4,850 | +54.7% | 0.00% | – |
Q3 2021 | $52,041,000 | +226.1% | 3,135 | +308.2% | 0.00% | – |
Q2 2021 | $15,959,000 | -57.8% | 768 | -61.9% | 0.00% | – |
Q1 2021 | $37,829,000 | -32.7% | 2,017 | -21.0% | 0.00% | – |
Q4 2020 | $56,170,000 | -14.6% | 2,552 | -19.4% | 0.00% | – |
Q3 2020 | $65,747,000 | +250.4% | 3,167 | +510.2% | 0.00% | – |
Q2 2020 | $18,762,000 | -76.6% | 519 | -78.9% | 0.00% | – |
Q1 2020 | $80,254,000 | +165.0% | 2,455 | +121.2% | 0.00% | – |
Q4 2019 | $30,281,000 | +4495.0% | 1,110 | +1750.0% | 0.00% | – |
Q3 2019 | $659,000 | – | 60 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,025,464 | $19,227,000 | 12.53% |
EMERALD MUTUAL FUND ADVISERS TRUST | 644,572 | $12,089,000 | 0.40% |
Orbimed Advisors | 2,257,387 | $42,337,000 | 0.40% |
EMERALD ADVISERS, LLC | 554,279 | $10,396,000 | 0.38% |
Rock Springs Capital Management LP | 701,680 | $13,160,000 | 0.29% |
DSAM Partners (London) Ltd | 67,125 | $1,259,000 | 0.23% |
AlphaCentric Advisors LLC | 33,000 | $619,000 | 0.21% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 639,458 | $11,993,000 | 0.18% |
Artal Group S.A. | 400,000 | $7,502,000 | 0.13% |
Virtus ETF Advisers LLC | 12,438 | $233,000 | 0.10% |